Impel NeuroPharma Inc. Recorded Big Gain
Thu, Nov 16, 2023 at 07:31 PM
Impel NeuroPharma Inc. (IMPL:NASDAQ) shot up at $0.36, a gain of 49.5%. On Thu, Nov 16, 2023, IMPL:NASDAQ touched a New 2-Week High of $0.36. The stock appeared on our News Catalysts scanner on Mon, Oct 30, 2023 at 05:06 PM in the 'MISCELLANEOUS' category. From Thu, Nov 02, 2023, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Thu, Nov 16, 2023 at $0.6 with a volume of 11M+.
About Impel NeuroPharma Inc. (IMPL:NASDAQ)
Impel NeuroPharma Inc is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases...
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 9900%
- Safe and Green Development Corporation (SGD:NASDAQ), 558.7%
- Alpha Technology Group Limited (ATGL:NASDAQ), 136.18%
- WaveDancer Inc. (WAVD:NASDAQ), 84.77%
- SG Blocks, Inc. (SGBX:NASDAQ), 82.02%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 65.05%
- KORE Group Holdings Inc. (KORE:NYSE), 58.87%
- Marpai Inc. (MRAI:NASDAQ), 58.06%
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 49.47%
- Northann Corp. (NCL:NYSEMKT), 48.58%